To include your compound in the COVID-19 Resource Center, submit it here.

Blocking the NAD+ biosynthesis enzyme NamPRT for PPM1D-mutant tumors

DISEASE CATEGORY: Cancer

INDICATION: Brain cancer; sarcoma; breast cancer

Inhibiting NamPRT, a nicotinamide adenine dinucleotide (NAD+) biosynthesis enzyme, could treat PPM1D-mutant cancers including glioma,

Read the full 222 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE